Zai Lab partners with Amgen for combination cancer therapy trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Amgen Inc (NASDAQ: AMGN) | Delayed: 448.70 +10.36 (2.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $438.34 | 52 Week High | $176.85 | |||
| Open | $441.55 | 52 Week Low | $133.64 | |||
| Day High | $450.98 | P/E | 67.58 | |||
| Day Low | $437.19 | EPS | $6.64 | |||
| Volume | 1,308,050 | |||||
| (NASDAQ: ZLAB) | Delayed: 21.84 -2.36 (9.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.20 | 52 Week High | $ | |||
| Open | $22.85 | 52 Week Low | $ | |||
| Day High | $22.88 | P/E | N/A | |||
| Day Low | $21.81 | EPS | $ | |||
| Volume | 583,657 | |||||
